Artificial Intelligence in the Development and Optimization of Nanocarriers

References

1. KhizarS. AlrushaidN. KhanA.F. ZineN. RenaultJ.N. ErrachidA. ElaissariA. Nanocarriers based novel and effective drug delivery system.Int. J. Pharm.202363212257010.1016/j.ijpharm.2022.122570 36587775
   [Google Scholar]
2. SharmaS. DangS. Nanocarrier-based drug delivery to brain: Interventions of surface modification.Curr. Neuropharmacol.202321351753510.2174/1570159X20666220706121412 35794771
   [Google Scholar]
3. TanP. ChenX. ZhangH. WeiQ. LuoK. Artificial intelligence aids in development of nanomedicines for cancer management.Seminars in Cancer Biology.Elsevier2023
   [Google Scholar]
4. MengardaA.C. IlesB. LongoJ.P.F. de MoraesJ. Recent approaches in nanocarrier‐based therapies for neglected tropical diseases.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.2023152e185210.1002/wnan.1852 36161523
   [Google Scholar]
5. DasK.P. J. C. Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges.Front. Med. Technol.20234106714410.3389/fmedt.2022.1067144 36688144
   [Google Scholar]
6. MilewskaS. Niemirowicz-LaskowskaK. SiemiaszkoG. NowickiP. WilczewskaA.Z. CarH. Current trends and challenges in pharmacoeconomic aspects of nanocarriers as drug delivery systems for cancer treatment.Int. J. Nanomedicine2021166593664410.2147/IJN.S323831 34611400
   [Google Scholar]
7. BaghaeiB. SaebM.R. JafariS.H. KhonakdarH.A. RezaeeB. GoodarziV. MohammadiY. Modeling and closed‐loop control of particle size and initial burst of PLGA biodegradable nanoparticles for targeted drug delivery.J. Appl. Polym. Sci.2017134334514510.1002/app.45145
   [Google Scholar]
8. AlshawwaS.Z. KassemA.A. FaridR.M. MostafaS.K. LabibG.S. Nanocarrier drug delivery systems: Characterization, limitations, future perspectives and implementation of artificial intelligence.Pharmaceutics202214488310.3390/pharmaceutics14040883 35456717
   [Google Scholar]
9. AshwiniT. NarayanR. ShenoyP.A. NayakU.Y. Computational modeling for the design and development of nano based drug delivery systems.J. Mol. Liq.2022368120596
   [Google Scholar]
10. HanR. XiongH. YeZ. YangY. HuangT. JingQ. LuJ. PanH. RenF. OuyangD. Predicting physical stability of solid dispersions by machine learning techniques.J. Control. Release2019311-312162510.1016/j.jconrel.2019.08.030 31465824
    [Google Scholar]
11. HeY. YeZ. LiuX. WeiZ. QiuF. LiH.F. ZhengY. OuyangD. Can machine learning predict drug nanocrystals?J. Control. Release202032227428510.1016/j.jconrel.2020.03.043 32234511
    [Google Scholar]
12. WangW. YeZ. GaoH. OuyangD. Computational pharmaceutics - A new paradigm of drug delivery.J. Control. Release202133811913610.1016/j.jconrel.2021.08.030 34418520
    [Google Scholar]
13. HashadR.A. IshakR.A.H. FahmyS. MansourS. GeneidiA.S. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.Int. J. Biol. Macromol.201686505810.1016/j.ijbiomac.2016.01.042 26783636
    [Google Scholar]
14. ThotaN. JiangJ. Computational amphiphilic materials for drug delivery.Front. Mater.201526410.3389/fmats.2015.00064
    [Google Scholar]
15. DuarteY. MirandaM.V. MiossecM.J. NiloG.F. Integration of target discovery, drug discovery and drug delivery: A review on computational strategies.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.2019114e155410.1002/wnan.1554 30932351
    [Google Scholar]